tetano
Editor, Senior Moderator
Clin Exp Nephrol
. 2022 May 15.
doi: 10.1007/s10157-022-02231-y. Online ahead of print.
New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan
Naoki Nakagawa[SUP] 1 2 [/SUP], Shoichi Maruyama[SUP] 3 4 [/SUP], Naoki Kashihara[SUP] 3 5 [/SUP], Ichiei Narita[SUP] 3 6 [/SUP], Yoshitaka Isaka[SUP] 3 7 [/SUP]
Affiliations
Abstract
Background: Recent clinical reports indicate a correlation between new-onset and relapse of nephrotic syndrome (NS) following coronavirus 2019 (COVID-19) vaccination in patients with glomerular diseases. However, there are no reports of a nationwide survey on NS following COVID-19 vaccination in Japan.
Methods: We conducted a web-based survey of council members of the Japanese Society of Nephrology (581 members, 382 facilities) to elucidate the relationship between COVID-19 vaccination and new-onset and relapse of NS.
Results: Following COVID-19 vaccination, 27 patients (male: 15, 55.6%) with new-onset (n = 6) and relapse (n = 21) of NS were reported. Of them, 12 (44.4%) patients were diagnosed with minimal change disease at the occurrence of NS. Five patients developed a slight increase in serum creatinine levels; however, none progressed to severe renal dysfunction.
Conclusion: Our findings clarify the clinical features of new-onset and relapse of NS following COVID-19 vaccination. Although there was no obvious progression to severe renal dysfunction, clinicians and pathologists should be aware that NS is a potential adverse effect of the vaccines.
Keywords: Coronavirus 2019; Minimal change disease; Nephrotic syndrome; SARS-CoV-2 vaccination; mRNA vaccination.
. 2022 May 15.
doi: 10.1007/s10157-022-02231-y. Online ahead of print.
New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan
Naoki Nakagawa[SUP] 1 2 [/SUP], Shoichi Maruyama[SUP] 3 4 [/SUP], Naoki Kashihara[SUP] 3 5 [/SUP], Ichiei Narita[SUP] 3 6 [/SUP], Yoshitaka Isaka[SUP] 3 7 [/SUP]
Affiliations
- PMID: 35569069
- DOI: 10.1007/s10157-022-02231-y
Abstract
Background: Recent clinical reports indicate a correlation between new-onset and relapse of nephrotic syndrome (NS) following coronavirus 2019 (COVID-19) vaccination in patients with glomerular diseases. However, there are no reports of a nationwide survey on NS following COVID-19 vaccination in Japan.
Methods: We conducted a web-based survey of council members of the Japanese Society of Nephrology (581 members, 382 facilities) to elucidate the relationship between COVID-19 vaccination and new-onset and relapse of NS.
Results: Following COVID-19 vaccination, 27 patients (male: 15, 55.6%) with new-onset (n = 6) and relapse (n = 21) of NS were reported. Of them, 12 (44.4%) patients were diagnosed with minimal change disease at the occurrence of NS. Five patients developed a slight increase in serum creatinine levels; however, none progressed to severe renal dysfunction.
Conclusion: Our findings clarify the clinical features of new-onset and relapse of NS following COVID-19 vaccination. Although there was no obvious progression to severe renal dysfunction, clinicians and pathologists should be aware that NS is a potential adverse effect of the vaccines.
Keywords: Coronavirus 2019; Minimal change disease; Nephrotic syndrome; SARS-CoV-2 vaccination; mRNA vaccination.